# Impact of prior antibiotic use on the efficacy of nivolumab for non‑small cell lung cancer

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/impact-of-prior-antibiotic-use-on-the-efficacy-of-nivolumab-for-non-small-cell/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Taiki Hakozaki,Yusuke Okuma,Miwako Omori,Yukio Hosomi |
| Citations | 120 |
| DOI | 10.3892/ol.2019.9899 |
| Fields | Biochemistry, Genetics and Molecular Biology,Medicine |
| Open Access | true |
| OA Status | diamond |
| OA URL | http://www.spandidos-publications.com/10.3892/ol.2019.9899/download |
| OpenAlex ID | https://openalex.org/W2909988858 |
| PMID | 30854072 |
| Type | article |
| Year | 2019 |

## Paper authors

- [Yusuke Okuma](https://scholariq.org/researchers/yusuke-okuma/)

## Paper journal

- [Oncology Letters](https://scholariq.org/journals/oncology-letters/)

## Paper primary topic

- [Cancer Immunotherapy and Biomarkers](https://scholariq.org/topics/cancer-immunotherapy-and-biomarkers/)

## Paper topics

- [Cancer Immunotherapy and Biomarkers](https://scholariq.org/topics/cancer-immunotherapy-and-biomarkers/)
- [Gut microbiota and health](https://scholariq.org/topics/gut-microbiota-and-health/)
- [Pancreatic and Hepatic Oncology Research](https://scholariq.org/topics/pancreatic-and-hepatic-oncology-research/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.